ficlatuzumab

Aveo regains full rights to ficlatuzumab as partner splits before phase 3
Fierce Biotech
Tue, 09/8/20 - 10:39 pm
Aveo Oncology
ficlatuzumab
Biodesix
clinical trials
Aveo gives up on ficlatuzumab in acute myeloid leukemia, citing COVID-19
Fierce Biotech
Mon, 03/30/20 - 10:33 am
Aveo Oncology
ficlatuzumab
AML
COVID-19
clinical trials
Aveo Oncology reports results of exploratory Phase 2 study of ficlatuzumab
Yahoo/Fly on the Wall
Mon, 10/1/12 - 10:41 am
Aveo Oncology
ficlatuzumab
gefitinib
non-small cell lung cancer